Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. VRDN
VRDN logo

VRDN

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

VRDN News

Viridian Reveals Partnership Agreement with Outside the Box Capital for Market Services

5d agomoomoo

Surge in Options Trading Volume for OraSure and Viridian

Apr 06 2026NASDAQ.COM

Amgen's Phase 3 Trial Success Leads to Viridian Stock Plunge

Apr 06 2026stocktwits

Viridian Therapeutics Shares Plummet: The Connection to an Amgen Study Explained.

Apr 06 2026Barron's

Stock Movers: Seagate, Micron, Tesla, Kratos, Strategy, Soleno, Viridian, and Others

Apr 06 2026Barron's

Biotech Landscape Update: Regulatory Approvals and Acquisitions

Apr 03 2026NASDAQ.COM

Immunovant Reports Disappointing Trial Results, Shares Drop

Apr 02 2026stocktwits

Mixed Close for US Stocks as Nasdaq Hits 7.75-Month Low Amid Middle East Tensions

Mar 30 2026NASDAQ.COM

Viridian Therapeutics Shares Plunge 32% Following Phase 3 Trial Results for Elegrobart

Mar 30 2026seekingalpha

US Stock Market Declines Amid Rising Oil Prices

Mar 30 2026NASDAQ.COM

Mixed U.S. Stock Indices Amid Rising Oil Prices

Mar 30 2026NASDAQ.COM

US Stocks Rise as Oil Prices Hit Three-Week High

Mar 30 2026NASDAQ.COM

Middle East Tensions Impact Global Markets

Mar 30 2026NASDAQ.COM

Viridian Therapeutics Shares Drop 31% Despite Positive Trial Results

Mar 30 2026NASDAQ.COM

Viridian Therapeutics Stock Plummets 35.3% Following Release of Late-Stage Trial Results for Thyroid Eye Disease Treatment

Mar 30 2026moomoo

Viridian Therapeutics Shares Plunge 41% After Phase 3 Trial Results

Mar 30 2026stocktwits